Recurrent Clostridium difficile Colitis: Case Series Involving 18 Patients Treated with Donor Stool Administered via a Nasogastric Tube

Aas, Johannes; Gessert, Charles E.; Bakken, Johan S.
March 2003
Clinical Infectious Diseases;3/1/2003, Vol. 36 Issue 5, p580
Academic Journal
Clostridium difficile--associated diarrhea and colitis have emerged as major complications associated with use of systemic antimicrobials. In this study, the medical records for 18 subjects who received donor stool by nasogastric tube for recurrent C. difficile infection during a 9-year period at a single institution were retrospectively reviewed. During the period between the initial diagnosis of C. difficile colitis and the stool treatments, the 18 subjects received a total of 64 courses of antimicrobials (range, 2-7 courses; median, 3 courses). During the 90 days after receipt of treatment with stool, 2 patients died of unrelated illnesses. One of the 16 survivors experienced a single recurrence of C. difficile colitis during 90-day follow-up. No adverse effects associated with stool treatment were observed. Patients with recurrent C. difficile colitis may benefit from the introduction of stool from healthy donors via a nasogastric tube.


Related Articles

  • Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals. Karasawa, Tadahiro; Nojiri, Takashi; Hayashi, Yasuhiro; Maegawa, Tsuneo; Yamakawa, Kiyotaka; Wang, Xing Min; Nakamura, Shinichi // Journal of Gastroenterology;1999, Vol. 34 Issue 1, p41 

    Abstract: Clostridium difficile causes pseudomembranous colitis and antibiotic-associated diarrhea. The definitive diagnosis of C. difficile infection is finally accomplished by the isolation of toxigenic C. difficile. However, only a small number of Japanese clinical laboratories are able to...

  • Clostridium difficile: A reemerging pathogen. Calfee, David P. // Geriatrics;Sep2008, Vol. 63 Issue 9, p10 

    The article presents a study which examines the incidence and severity of Clostridium difficile infection (CDI). An anaerobic, gram-positive, spore-forming bacterium, Clostridium difficile is associated with various conditions, such as pseudomembranous colitis, antibiotic-associated diarrhea,...

  • Clostridium difficile-associated diarrhea in adults. Poutanen, Susan M.; Simor, Andrew E. // CMAJ: Canadian Medical Association Journal;7/6/2004, Vol. 171 Issue 1, p51 

    CLOSTRIDIUM DIFFICILE IS THE MOST IMPORTANT CAUSE of nosocomial diarrhea in adults. Illness may range from mild watery diarrhea to life-threatening colitis. An antecedent disruption of the normal colonic flora followed by exposure to a toxigenic strain of C. diffi-cile are necessary first...

  • Low Occurrence of Clostridium difficile in Fecal Samples Healthy Calves and Pigs at Slaughter and in Minced Meat in Switzerland. HOFER, E.; HAECHLER, H.; FREI, R.; STEPHAN, R. // Journal of Food Protection;May2010, Vol. 73 Issue 5, p973 

    Clostridium difficile is a cause of diarrhea and colitis in humans. The increase of incidence and severity of C. difficile infections in humans in past years is due, at least in part, to the emergence of more virulent strains (PCR ribotypes 027 and 078). Recent studies describe the occurrence of...

  • Absence of Diarrhea in Toxic Megacolon Complicating Clostridium difficile Pseudomembranous Colitis. Burke, George W.; Wilson, Mary E.; Mehrez, Isaac O. // American Journal of Gastroenterology;Mar1988, Vol. 83 Issue 3, p304 

    We describe a patient with Clostridium difficile-associated pseudomembranous colitis who presented with toxic megacolon without diarrhea. The discussion includes a brief review of the literature, and suggests an important role for endoscopy in the diagnosis of pseudomembranous colitis...

  • Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections. Mullane, Kathleen M.; Miller, Mark A.; Weiss, Karl; Lentnek, Arnold; Golan, Yoav; Sears, Pamela S.; Shue, Youe-Kong; Louie, Thomas J.; Gorbach, Sherwood L. // Clinical Infectious Diseases;9/1/2011, Vol. 53 Issue 5, p440 

    Background. Treatment guidelines recommend stopping all implicated antibiotics at the onset of Clostridium difficile infection (CDI), but many individuals have persistent or new infections necessitating the use of concomitant antibiotics (CAs). We used data from 2 phase 3 trials to study effects...

  • Predictors of Mortality and Morbidity in Clostridium Difficile Infection. Dixon, Jill; Menezes, Brian F. // Annals of Medicine & Healthcare Research;2009, p577 

    Clostridium Difficile (CD) is implicated in 20 to 30% of patients with antibiotic-associated diarrhoea, in 50 to 70% of those with antibiotic-associated colitis and in more than 90% of those with antibiotic-associated pseudomembranous colitis1-4. The incidence of CD associated diarrhoea ranges...

  • Clostridium difficile associated infection, diarrhea and colitis. Hookman, Perry; Barkin, Jamie S.; Freeman, Hugh J. // World Journal of Gastroenterology;4/7/2009, Vol. 15 Issue 13, p1554 

    A new, hypervirulent strain of Clostridium difficile, called NAP1/BI/027, has been implicated in C. difficile outbreaks associated with increased morbidity and mortality since the early 2000s. The epidemic strain is resistant to fluoroquinolones in vitro, which was infrequent prior to 2001. The...

  • Intestinal Superbug Claims More Lives. Lockwood, Amy E. // Homeopathy Today;Apr2006, Vol. 26 Issue 2, p28 

    The article reports on the spread of Clostridium difficile (C-diff), a toxin-producing bacteria that is considered as one of the primary causes of diarrhea, colitis and death each year in the U.S. Medical experts had identified several contributory factors to the increased virulence of C-diff,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics